CCCC
Price
$2.33
Change
+$0.02 (+0.87%)
Updated
Jan 14 closing price
Capitalization
225.81M
35 days until earnings call
Intraday BUY SELL Signals
NVAX
Price
$8.19
Change
-$0.48 (-5.54%)
Updated
Jan 14 closing price
Capitalization
1.33B
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs NVAX

Header iconCCCC vs NVAX Comparison
Open Charts CCCC vs NVAXBanner chart's image
C4 Therapeutics
Price$2.33
Change+$0.02 (+0.87%)
Volume$1.03M
Capitalization225.81M
Novavax
Price$8.19
Change-$0.48 (-5.54%)
Volume$7.55M
Capitalization1.33B
CCCC vs NVAX Comparison Chart in %
View a ticker or compare two or three
VS
CCCC vs. NVAX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and NVAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CCCC: $2.33 vs. NVAX: $8.19)
Brand notoriety: CCCC: Not notable vs. NVAX: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 63% vs. NVAX: 196%
Market capitalization -- CCCC: $225.81M vs. NVAX: $1.33B
CCCC [@Biotechnology] is valued at $225.81M. NVAX’s [@Biotechnology] market capitalization is $1.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileNVAX’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • NVAX’s FA Score: 1 green, 4 red.
According to our system of comparison, NVAX is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while NVAX’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 6 bearish.
  • NVAX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NVAX is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а +4.95% price change this week, while NVAX (@Biotechnology) price change was +7.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

CCCC is expected to report earnings on Feb 19, 2026.

NVAX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVAX($1.33B) has a higher market cap than CCCC($226M). CCCC (21.990) and NVAX (21.875) have similar YTD gains . NVAX has higher annual earnings (EBITDA): 410M vs. CCCC (-105.05M). NVAX has more cash in the bank: 763M vs. CCCC (192M). CCCC has less debt than NVAX: CCCC (61.5M) vs NVAX (251M). NVAX has higher revenues than CCCC: NVAX (1.07B) vs CCCC (30.1M).
CCCCNVAXCCCC / NVAX
Capitalization226M1.33B17%
EBITDA-105.05M410M-26%
Gain YTD21.99021.875101%
P/E RatioN/A4.07-
Revenue30.1M1.07B3%
Total Cash192M763M25%
Total Debt61.5M251M25%
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCNVAX
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signal:
Gain/Loss:
NVAX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SUVCX10.140.03
+0.30%
PGIM Quant Solutions Large-Cap Val C
WVAIX45.33N/A
N/A
Weitz Large Cap Equity-Institutional Cl
GCEGX11.60-0.01
-0.09%
Goldman Sachs Clean Energy Income C
NRACX53.75-0.26
-0.48%
Neuberger Quality Equity C
PRMTX129.85-1.19
-0.91%
T. Rowe Price Comm & Tech Investor

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with GLUE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then GLUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+0.87%
GLUE - CCCC
40%
Loosely correlated
+0.29%
BEAM - CCCC
40%
Loosely correlated
+2.49%
AXON - CCCC
40%
Loosely correlated
-1.92%
XNCR - CCCC
40%
Loosely correlated
+3.66%
VYGR - CCCC
38%
Loosely correlated
+2.74%
More

NVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVAX has been loosely correlated with MRNA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NVAX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVAX
1D Price
Change %
NVAX100%
-5.54%
MRNA - NVAX
57%
Loosely correlated
+2.47%
BNTX - NVAX
44%
Loosely correlated
+1.80%
FHTX - NVAX
41%
Loosely correlated
-5.54%
XNCR - NVAX
39%
Loosely correlated
+3.66%
CCCC - NVAX
39%
Loosely correlated
+0.87%
More